Jeffrey M. Hubbard, Ph.D. - Publications

2013- Brain and Spine Institute (ICM), Paris, France 
Synaptic physiology, neural circuits

5/41 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Bercier V, Hubbard JM, Fidelin K, Duroure K, Auer TO, Revenu C, Wyart C, Del Bene F. Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities. Molecular Neurodegeneration. 14: 27. PMID 31291987 DOI: 10.1186/s13024-019-0327-3  0.4
2016 Sternberg JR, Severi KE, Fidelin K, Gomez J, Ihara H, Alcheikh Y, Hubbard JM, Kawakami K, Suster M, Wyart C. Optimization of a Neurotoxin to Investigate the Contribution of Excitatory Interneurons to Speed Modulation In Vivo. Current Biology : Cb. PMID 27524486 DOI: 10.1016/j.cub.2016.06.037  0.4
2013 Wen H, Hubbard JM, Rakela B, Linhoff MW, Mandel G, Brehm P. Synchronous and asynchronous modes of synaptic transmission utilize different calcium sources. Elife. 2: e01206. PMID 24368731 DOI: 10.7554/eLife.01206  0.52
2013 Wen H, Linhoff MW, Hubbard JM, Nelson NR, Stensland D, Dallman J, Mandel G, Brehm P. Zebrafish calls for reinterpretation for the roles of P/Q calcium channels in neuromuscular transmission. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7384-92. PMID 23616544 DOI: 10.1523/JNEUROSCI.5839-12.2013  0.52
2007 Koch HP, Hubbard JM, Larsson HP. Voltage-independent sodium-binding events reported by the 4B-4C loop in the human glutamate transporter excitatory amino acid transporter 3. The Journal of Biological Chemistry. 282: 24547-53. PMID 17588938 DOI: 10.1074/jbc.M704087200  0.52
Low-probability matches
2015 Hubbard JM, Kim G, Borad MJ, Johnson E, Qin R, Lensing J, Puttabasavaiah S, Wright J, Erlichman C, Grothey A. Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies. Investigational New Drugs. PMID 26581401 DOI: 10.1007/s10637-015-0308-5  0.01
2007 Iken K, Amsler CD, Hubbard JM, McClintock JB, Baker BJ. Allocation patterns of phlorotannins in Antarctic brown algae Phycologia. 46: 386-395. DOI: 10.2216/06-67.1  0.04
2005 Amsler CD, Iken K, McClintock JB, Amsler MO, Peters KJ, Hubbard JM, Furrow FB, Baker BJ. Comprehensive evaluation of the palatability and chemical defenses of subtidal macroalgae from the Antarctic Peninsula Marine Ecology Progress Series. 294: 141-159.  0.04
1996 Koch AS, Harbison WG, Hubbard JM, De Kort M, Roe BA. Stability of pyridiniumylquinones to aqueous media: The formation of pyridinium-oxy zwitterionic quinones Journal of Organic Chemistry. 61: 5959-5963.  0.01
2016 Hubbard JM. Management of Colorectal Cancer in Older Adults. Clinics in Geriatric Medicine. 32: 97-111. PMID 26614863 DOI: 10.1016/j.cger.2015.08.002  0.01
2015 Pachman DR, Ruddy K, Sangaralingham LR, Grothey A, Shah ND, Beutler AS, Hubbard JM, Loprinzi CL. Calcium and Magnesium Use for Oxaliplatin-Induced Neuropathy: A Case Study to Assess How Quickly Evidence Translates Into Practice. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 1097-101. PMID 26358793  0.01
2015 Thanarajasingam G, Hubbard JM, Sloan JA, Grothey A. The Imperative for a New Approach to Toxicity Analysis in Oncology Clinical Trials. Journal of the National Cancer Institute. 107. PMID 26232762 DOI: 10.1093/jnci/djv216  0.01
2015 Kasi PM, Thanarajasingam G, Finnes HD, Villasboas Bisneto JC, Hubbard JM, Grothey A. Chemotherapy in the Setting of Severe Liver Dysfunction in Patients with Metastatic Colorectal Cancer. Case Reports in Oncological Medicine. 2015: 420159. PMID 26090248 DOI: 10.1155/2015/420159  0.01
2015 Hubbard JM, Grothey A. When less is more: maintenance therapy in colorectal cancer. Lancet (London, England). 385: 1808-10. PMID 25862518 DOI: 10.1016/S0140-6736(14)62350-3  0.01
2015 Kasi PM, Hubbard JM, Grothey A. Selection of biologics for patients with metastatic colorectal cancer: the role of predictive markers. Expert Review of Gastroenterology & Hepatology. 9: 273-6. PMID 25579664 DOI: 10.1586/17474124.2015.1001743  0.01
2015 Hubbard JM, Grothey A. Colorectal cancer in 2014: progress in defining first-line and maintenance therapies. Nature Reviews. Clinical Oncology. 12: 73-4. PMID 25560533 DOI: 10.1038/nrclinonc.2014.233  0.01
2015 Hubbard JM, Jatoi A. Incorporating biomarkers of frailty and senescence in cancer therapeutic trials. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 70: 722-8. PMID 24770389 DOI: 10.1093/gerona/glu046  0.01
2015 Halfdanarson TR, Hubbard JM. Metastatic rectal cancer Modern Management of Cancer of the Rectum. 287-310. DOI: 10.1007/978-1-4471-6609-2_20  0.01
2014 Hubbard JM, Cohen HJ, Muss HB. Incorporating biomarkers into cancer and aging research. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2611-6. PMID 25071114 DOI: 10.1200/JCO.2014.55.4261  0.01
2014 Gonsalves WI, Mahoney MR, Sargent DJ, Nelson GD, Alberts SR, Sinicrope FA, Goldberg RM, Limburg PJ, Thibodeau SN, Grothey A, Hubbard JM, Chan E, Nair S, Berenberg JL, McWilliams RR, et al. Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147. Journal of the National Cancer Institute. 106. PMID 24925349 DOI: 10.1093/jnci/dju106  0.01
2014 Sridharan M, Hubbard JM, Grothey A. Colorectal cancer: how emerging molecular understanding affects treatment decisions. Oncology (Williston Park, N.Y.). 28: 110-8. PMID 24701697  0.01
2014 Hubbard JM, Grothey AF, McWilliams RR, Buckner JC, Sloan JA. Physician perspective on incorporation of oncology patient quality-of-life, fatigue, and pain assessment into clinical practice. Journal of Oncology Practice / American Society of Clinical Oncology. 10: 248-53. PMID 24667294 DOI: 10.1200/JOP.2013.001276  0.01
2014 Hubbard JM, Grothey A. The challenge to optimize medical therapy for advanced colorectal cancer. Journal of the National Cancer Institute. 106: djt442. PMID 24511110 DOI: 10.1093/jnci/djt442  0.01
2014 Lapid MI, Atherton PJ, Clark MM, Kung S, Richardson JW, Cheville AL, Dyrbye LN, Hubbard JM, Piderman KM, Shanafelt TD, Sloan JA, West CP, Schott DK, Rummans TA. Geriatric and non-geriatric cancer caregivers: Perceived benefits of technology Gerontechnology. 13: 231. DOI: 10.4017/gt.2014.  0.01
2013 Hubbard JM, Grothey A. Adolescent and young adult colorectal cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 11: 1219-25. PMID 24142823  0.01
2013 Xu YF, Prudencio M, Hubbard JM, Tong J, Whitelaw EC, Jansen-West K, Stetler C, Cao X, Song J, Zhang YJ. The pathological phenotypes of human TDP-43 transgenic mouse models are independent of downregulation of mouse Tdp-43. Plos One. 8: e69864. PMID 23922830 DOI: 10.1371/journal.pone.0069864  0.01
2013 Hubbard JM, Alberts SR. Alternate dosing of cetuximab for patients with metastatic colorectal cancer. Gastrointestinal Cancer Research : Gcr. 6: 47-55. PMID 23745159  0.01
2011 Hubbard JM, Grothey A, Sargent DJ. Systemic therapy for elderly patients with gastrointestinal cancer. Clinical Medicine Insights. Oncology. 5: 89-99. PMID 21603244 DOI: 10.4137/CMO.S6983  0.01
2010 Hubbard JM, Alberts SR. Treatment of liver-limited metastatic colorectal cancer. Cancer Journal (Sudbury, Mass.). 16: 235-40. PMID 20526102 DOI: 10.1097/PPO.0b013e3181e075e9  0.01
2008 Parker R, Adams JL, Ogola G, McBrayer D, Hubbard JM, McCullough TL, Hartman JM, Cleveland T. Current activity guidelines for CABG patients are too restrictive: comparison of the forces exerted on the median sternotomy during a cough vs. lifting activities combined with valsalva maneuver. The Thoracic and Cardiovascular Surgeon. 56: 190-4. PMID 18481235 DOI: 10.1055/s-2008-1038470  0.01
2005 Higgins DL, Chang R, Debabov DV, Leung J, Wu T, Krause KM, Sandvik E, Hubbard JM, Kaniga K, Schmidt DE, Gao Q, Cass RT, Karr DE, Benton BM, Humphrey PP. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49: 1127-34. PMID 15728913 DOI: 10.1128/AAC.49.3.1127-1134.2005  0.01
2003 Kelley JR, Fraser MM, Hubbard JM, Watson DK, Cole DJ. CaSm antisense gene therapy: a novel approach for the treatment of pancreatic cancer. Anticancer Research. 23: 2007-13. PMID 12894573  0.01
1993 Wang D, Hubbard JM, Kabat EA. Modeling study of antibody combining sites to (alpha 1-6)dextrans. Predictions of the conformational contribution of VL-CDR3 and J kappa segments to groove-type combining sites. The Journal of Biological Chemistry. 268: 20584-9. PMID 7690758  0.01
1991 Hubbard JM, Hearst JE. Predicting the three-dimensional folding of transfer RNA with a computer modeling protocol. Biochemistry. 30: 5458-65. PMID 2036414  0.01
1991 Hubbard JM, Hearst JE. Computer modeling 16 S ribosomal RNA. Journal of Molecular Biology. 221: 889-907. PMID 1942035 DOI: 10.1016/0022-2836(91)80182-T  0.01
1991 Glasser SP, Clark PI, Lipicky RJ, Hubbard JM, Yusuf S. Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials. Jama. 265: 1550-4. PMID 1671885 DOI: 10.1001/jama.1991.03460120064037  0.01
1990 Lockey RF, Turkeltaub PC, Olive ES, Hubbard JM, Baird-Warren IA, Bukantz SC. The Hymenoptera venom study. III: Safety of venom immunotherapy. The Journal of Allergy and Clinical Immunology. 86: 775-80. PMID 2229842 DOI: 10.1016/S0091-6749(05)80182-4  0.01
1987 Curry SC, Hubbard JM, Gerkin R, Selden B, Ryan PJ, Meinhart R, Hagner D. Lack of correlation between plasma 4-hydroxyglutethimide and severity of coma in acute glutethimide poisoning. A case report and brief review of the literature. Medical Toxicology and Adverse Drug Experience. 2: 309-16. PMID 3626855 DOI: 10.1007/BF03259872  0.01
1986 Holliman WB, Soileau GA, Hubbard JM, Stevens J. Consent requirements and anxiety in university undergraduate students. Psychological Reports. 59: 175-8. PMID 3737799 DOI: 10.2466/pr0.1986.59.1.175  0.01
1982 Ferslew KE, Manno JE, Manno BR, Vekovius WA, Hubbard JM, Bairnsfather LE. Pursuit Meter II, a computer-based device for testing pursuit-tracking performance. Perceptual and Motor Skills. 54: 779-84. PMID 7099887 DOI: 10.2466/pms.1982.54.3.779  0.01
1879 Hubbard JM. "Macbeth,.... with notes and emendations by Harry Rowe,.... master of a puppet show" Notes and Queries. 397-398. DOI: 10.1093/nq/s5-XI.281.397-e  0.01
Hide low-probability matches.